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Breast-Feeding Duration and Infant Atopic Manifestations, by Maternal
Allergic Status, in the First 2 Years of Life (KOALA Study)
BIANCA E. P. SNIJDERS, MSC, CAREL THIJS, MD, PHD, PIETER C. DAGNELIE, PHD, FOEKJE F. STELMA, MD, PHD,
MONIQUE MOMMERS, PHD, ISCHA KUMMELING, PHD, JOHN PENDERS, PHD, RONALD VAN REE, PHD, AND
PIET A. VAN DEN BRANDT, PHD
bjective To investigate the potential effect of modification by maternal allergic status on the relationship between
reast-feeding duration and infant atopic manifestations in the first 2 years of life.
tudy design Data from 2705 infants of the KOALA Birth Cohort Study (The Netherlands) were analyzed. The data were
ollected by repeated questionnaires at 34 weeks of gestation and 3, 7, 12, and 24 months postpartum. Total and specific
mmunoglobulin E measurements were performed on venous blood samples collected during home visits at age 2 years.
elationships were analyzed using logistic regression analyses.
esults Longer duration of breast-feeding was associated with a lower risk for eczema
n infants of mothers without allergy or asthma (Ptrend  .01) and slightly lower risk in
hose of mothers with allergy but no asthma (Ptrend  .14). There was no such associa-
ion for asthmatic mothers (Ptrend  .87). Longer breast-feeding duration decreased the
isk of recurrent wheeze independent of maternal allergy (Ptrend  .02) or asthma status
Ptrend  .06).
onclusions Our findings show that the relationship between breast-feeding and
nfant eczema in the first 2 years of life is modified by maternal allergic status. The
rotective effect of breast-feeding on recurrent wheeze may be associated with protec-
ion against respiratory infections. (J Pediatr 2007;151:347-51)
he role of breast-feeding in allergic disease remains a matter of debate. The
postulated protective effect of breast-feeding may act through several mecha-
nisms. One possible mechanism is through the exclusion of potentially allergic
omponents, like cow’s milk or food products introduced in the infant’s diet. Alternatively,
reast-feeding provides the infant with immunomodulatory, anti-inflammatory, nutri-
ional, and other components present in human breast milk.
Wright et al1 reported higher immunoglobulin E (IgE) levels in breast-fed children
ompared with never breast-fed children of mothers with high IgE levels. A study of
avarian farmers study found an increased risk for doctor-diagnosed asthma related to
reast-feeding in children whose mothers had asthma themselves.2 In children of asth-
atic mothers, longer exclusive breast-feeding was found to be associated with a greater
isk of asthma, but asthma was unrelated to feeding status in children without maternal
sthma.3 In contrast, an Australian study found an association between exclusive breast-
eeding and a statistically significant lower risk of asthma that was independent of
aternal asthma and the child’s atopic status.4
In the present study, we examined whether maternal allergy or asthma status is an
ffect modifier in the relationship between breast-feeding duration and the development
f infant atopic manifestations (eczema, recurrent wheeze) in the first 2 years of life. We
lso studied the relationships between breast-feeding duration and increased total IgE
I Confidence interval OR Odds ratio
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3evels and allergic sensitization at age 2 in children of mothers
ith and without increased total IgE levels or sensitization.
METHODS
tudy Population
The study subjects were mother–infant pairs previously
nrolled in the KOALA Birth Cohort Study between 2000
nd 2002.5 We recruited participants with diverse lifestyles
“conventional” and “alternative”) who were at 34 weeks of
estation. The women with a conventional lifestyle (n 
343) were recruited from an ongoing prospective cohort
tudy on pregnancy-related pelvic girdle pain in The Neth-
rlands. The women with an alternative lifestyle (n  491)
ere recruited through various channels, including organic
ood shops, anthroposophic doctors and midwives, Steiner
chools, and magazines. The study design was approved by
he Ethics Committee of Maastricht University, and all par-
nts signed written informed consent.
ata Collection
During pregnancy and throughout the first 2 years of
he child’s life, information on breast-feeding, other determi-
ants, and atopic manifestations was collected for all members
f the cohort by repeated questionnaires at 34 weeks of
estation and at 3, 7, 12, and 24 months after birth. Home
isits to children age 2 years by trained nurses to collect blood
amples and perform clinical examination by trained nurses,
sing UK Working Party (UK-WP) criteria were started in
eptember 2004.
All infants of participants (n  2834) with a completed
nformed consent and the presence of the first questionnaire
34 weeks of gestation) were included in the study. We
xcluded infants with congenital diseases known to affect
mmunity, such as Down syndrome, and those with missing
nformation on the main determinant, breast-feeding.
reast-Feeding Exposure
Breast-feeding was categorized as follows, according to
he age at which breast-feeding was stopped: never breast-fed
reference category), 0 to 3 months, 4 to 6 months, 7 to 9
onths, and 9 months.
aternal Allergic History
To study effect modification by maternal allergy or
sthma on the relationship between breast-feeding duration
nd infant eczema and recurrent wheeze, we defined 3 strata:
1) no maternal allergy or asthma; (2) maternal allergy, no
sthma, defined as self reported doctor’s diagnosed eczema,
llergy for house dust mite/pets, or allergic rhinoconjunctivitis
eg, hay fever); and (3) maternal asthma, defined as self-
eported or physician-diagnosed asthma, irrespective of other
llergic diseases. Maternal increased total IgE levels and sen-
itization were both defined as present (yes/no). c
48 Snijders et alnfant Atopic Manifestations
Eczema (by Questionnaire, Adapted from International
tudy of Asthma and Allergies in Childhood).
In the 7-, 12-, and 24-month postpartum question-
aires, parents were asked: “Has your child ever had an itchy
ash that came and went in the past months?” If the parent
nswered “yes” at least once, the infant was defined as having
eveloped eczema in the first 2 years of life. Cases of diaper
ash, rash around the eyes, or scalp scaling were excluded.
topic Dermatitis (According to UK-WP Criteria)
To specify eczema reported by parents as described
arlier, we defined atopic dermatitis according to UK-WP
riteria6 for all infants who were visited at home at age 2 years.
n this study, infants with a UK-WP atopic dermatitis prob-
bility score 0.9 were considered as having probable pres-
nce of atopic dermatitis.
Recurrent wheezing in the first 2 years of life was
efined as reported presence of wheezing with at least 4
ttacks between age 0 and 7 months and mentioned in the
-month postpartum questionnaire, between age 7 and 12
onths and mentioned in the 12-month postpartum ques-
ionnaire, or between age 13 and 24 months and mentioned in
he 24-month postpartum questionnaire.
easurements and Definitions of Allergic Sensitization
Mother and Infant)
Maternal venous blood samples were obtained during
ome visits at 34 to 36 weeks of gestation. Infants’ venous
lood samples were obtained during home visits at 2 years
ostpartum. Total IgE levels were analyzed as described ear-
ier.7,8 For values 150 IU/mL, a sandwich radioimmunoas-
ay (RIA) was used;7 for values 150 IU/mL, a competitive
IA was used.8 All blood samples were analyzed for specific
gE against hen’s eggs, cow’s milk, peanuts, birch, grass
ollen, cat, dog, and house dust mite using a radioallergosor-
ent test as described previously.8 Calculation was performed
y means of a standard curve obtained by radioallergosorbent
esting with a dilution series of a chimeric monoclonal IgE
ntibody against the major allergen Der p 2 and Sepharose-
oupled recombinant Der p 2.9 The detection limits for total
nd specific IgE were 0.50 IU/mL and 0.10 IU/mL, respec-
ively. High maternal total IgE was arbitrarily defined as total
gE level 100 IU/mL; high total IgE for infants was arbi-
rarily defined as total IgE level 10 IU/mL. Mother and
nfant were considered sensitized if specific serum IgE levels
ere 0.3 IU/mL against at least 1 of the food or inhalant
llergens tested.
tatistical Analysis
Relationships were analyzed using logistic regression.
esults are presented as unadjusted odds ratios (OR) and
djusted ORs with corresponding 95% confidence intervals
CIs). All potential confounders were simultaneously in-
luded in the logistic regression model to adjust the analyses.
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Botential confounders were (1) age at introduction of cow’s
ilk products, defined as artificial formulas (including hy-
oallergenic formulas), (raw) milk, porridge, yogurt, and
ther dairy products, categorized according to age at first
ntroduction as 0 to 3 months, 4 to 6 months, 7 to 9 months,
nd after 9 months, and (2) age at introduction of other food
roducts (eg, fruit mash), categorized according to the age at
rst introduction as 0 to 3 months, 4 to 6 months, and after
months. Other potential confounders were infant’s sex,
ecruitment group (conventional/alternative lifestyle), antibi-
tic medication (yes/no), maternal smoking during pregnancy
yes/no), infant’s exposure to environmental tobacco smoke
yes/no), maternal age at delivery, maternal education (pri-
ary school, preparatory vocational or lower general second-
ry education [low], vocational education, higher general sec-
ndary or pre-university education [middle], or higher
ocational or academic education [high]), presence of paternal
llergic disease (yes/no), number of siblings (no siblings, 1
ibling, or 2 or more siblings), and presence of older allergic
iblings (no siblings, older allergic sibling[s], or older nonal-
ergic sibling[s]).
To assess whether our results were prone to reverse
ausation (by introducing hypoallergenic formulas after the
evelopment of eczema), we explored the use of hypoaller-
enic formulas associated with atopic manifestations. For the
est for trend, we repeated the logistic regression analyses with
he categories of breast-feeding duration (coded as 1 to 5) as
continuous variable in the logistic regression analyses, again
djusting for all potential confounders. Effect modification by
ecruitment group was assessed using the likelihood ratio test,
omparing models with and without interaction terms.
RESULTS
Of the 2834 infants enrolled at birth, 3 were excluded
ecause of Down syndrome and 126 because of missing
nformation on breast-feeding, leaving 2705 infants for the
tudy. The response rate for the questionnaire at age 2 years
as 93% (n 2516). Home visits at age 2 years were made in
18 infants. Most infants were breast-fed (85%; n  2287).
others in the alternative recruitment group had a higher
ate and a longer duration of breast-feeding compared with
hose in the conventional recruitment group (Table I; avail-
ble at www.jpeds.com). Also, they showed greater delay in
he age of introduction of cow’s milk products (Table I).
ther characteristics that differed between both groups were
aternal age, maternal smoking during pregnancy, environ-
ental tobacco smoking, maternal education, number of sib-
ings, and antibiotic medication use (Table I).
Infants receiving hypoallergenic formulas at any time
etween birth and age 3 months (n  185) showed a higher
isk of eczema in the first 2 years of life compared with infants
iven nonhypoallergenic formula feeding (unadjusted OR 
.81; 95% CI  1.31 to 2.49) even when adjusting for all
otential confounders (adjusted OR  1.97; 95% CI  1.30
o 3.00). Because these results may be explained by reverse
ausation (ie, hypoallergenic formulas were introduced after b
reast-Feeding Duration and Infant Atopic Manifestations, by Maternal Ahe development of eczema), we excluded the participants
ho introduced hypoallergenic formulas (0 to 3 months) from
ll subsequent analyses.
Overall, longer breast-feeding duration showed a sta-
istically significant trend toward a lower risk of eczema
Ptrend  .03, adjusted for confounders). Longer duration
f breast-feeding was associated with a statistically signif-
cant lower risk for eczema in infants of mothers without
llergy or asthma (Ptrend  .01; Table II). In mothers with
llergy but no asthma, the results trended in the same
irection but were not statistically significant (Ptrend  .14;
able II). For asthmatic mothers, there was no (inverse)
ssociation between breast-feeding duration and infant ec-
ema (Ptrend  .87; Table II). There was no association
etween breast-feeding duration and atopic dermatitis ac-
ording to UK-WP criteria (n  866; number of cases 
17) in either the overall analysis or the 3 different mater-
al strata (results not shown; Ptrend  .05).
Longer breast-feeding duration was associated with a
ower risk of recurrent wheeze in infants of mothers with no
llergy or asthma (Ptrend  .02), with allergy but no asthma
Ptrend  .02), and with asthma (Ptrend  .06). The breast-
eeding category 7 to 9 months showed the lowest risk of
nfant recurrent wheeze in all groups (OR  0.11; 95% CI 
.02 to 0.70) (Table II).
Duration of breast-feeding did not influence the risk of
igh total IgE levels in infants of mothers who themselves
ad increased total IgE levels or in mothers with normal IgE
evels (Table III; available at www.jpeds.com). Also, we found
o association between breast-feeding duration and infant
ensitization in infants of mothers with or without sensitiza-
ion (Table III).
The differences in the ORs of unadjusted and adjusted
nalyses (Table II) were the result of strong confounding
ffects of a positive paternal history of allergic disease, age at
ntroduction of cow’s milk and other food products, and
nfant’s use of antibiotics.
DISCUSSION
We found that longer duration of breast-feeding was
ssociated with a decreased risk for recurrent wheeze in the
rst 2 years of life, regardless of the mother’s allergy history.
oreover, longer duration of breast-feeding was associated
ith a decreased risk of eczema (by questionnaire) in infants
f mothers without allergy or asthma. When atopic dermatitis
according to UK-WP criteria), increased total IgE levels, or
ensitization were taken as the outcome, no associations with
reast-feeding duration were found.
Overall, our results for eczema provide evidence of a
rotective effect of breast-feeding. We found a protective
ffect of breast-feeding duration on eczema in the first 2 years
f life in mothers without allergy or asthma; this effect was
ess clear in mothers with allergy but no asthma and absent in
others with maternal asthma. These findings imply effect
odification by maternal allergic status for the relationshipetween breast-feeding and infant eczema. Nevertheless,
llergic Status, in the First 2 Years of Life (KOALA Study) 349
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3hese results need to be interpreted with caution because only
others without allergy or asthma who breast-fed for 9
onths showed a statistically significantly lower risk for ec-
ema in the first 2 years of life. In addition, the different
esults in the 3 maternal strata may be explained by differing
eporting behaviors on symptoms of infant eczema between
others with or without allergy and/or asthma.
Infants’ eczema and sensitization were considered as
eparate outcomes instead of combining them as atopic ec-
ema, because sensitized infants do not necessarily exhibit
ymptoms of eczema and vice versa.10 Consequently, we use
he term “eczema” instead of “atopic eczema.” On the other
and, we use the term “atopic dermatitis” for infants fulfilling
he UK-WP criteria according to Williams et al.6 The asso-
iations between breast-feeding and eczema could not be
onfirmed by our results on atopic dermatitis according to the
K-WP criteria. We speculate that breast-feeding is associ-
ted only with a milder eczematous condition that has already
isappeared at the time of the home visit. Another explana-
able II. Associations between breast-feeding duratio
ecurrent wheeze during the first 2 years of life acco
other
Infant eczema
Maternal status N n (%) OR (95% CI) ORad
o allergy, no
asthma
BF
Never 231 61 (26%) 1.00
0 to 3 months 494 132 (27%) 1.02 (0.71 to 1.45) 0.90 (
4 to 6 months 259 70 (27%) 1.03 (0.69 to 1.54) 0.71 (
7 to 9 months 245 74 (30%) 1.21 (0.81 to 1.80) 0.69 (
9 months 309 75 (24%) 0.89 (0.60 to 1.32) 0.51 (
trend .83
aternal allergy,
no asthma
BF
Never 87 27 (31%) 1.00
0 to 3 months 215 71 (33%) 1.10 (0.64 to 1.87) 0.90 (
4 to 6 months 111 43 (39%) 1.41 (0.78 to 2.54) 0.86 (
7 to 9 months 114 42 (37%) 1.30 (0.72 to 2.34) 0.68 (
9 months 125 46 (37%) 1.29 (0.72 to 2.32) 0.63 (
trend .28
aternal asthma
BF
Never 27 7 (26%) 1.00
0 to 3 months 75 28 (37%) 1.70 (0.64 to 4.53) 1.39 (
4 to 6 months 36 15 (42%) 2.04 (0.69 to 6.05) 1.40 (
7 to 9 months 37 12 (32%) 1.37 (0.46 to 4.13) 0.70 (
9 months 42 22 (52%) 3.14 (1.10 to 9.00) 1.67 (
trend .08
ay not add up to total numbers because of missing values.
F, breast-feeding; ORadj , adjusted odds ratio.
Based on logistic regression analysis adjusted for: the age at introduction of cow’s milk
se of antibiotics, maternal smoking during pregnancy, infant’s exposure to environmen
isease, number of siblings and presence of older allergic siblings.ion for these discrepant findings is that the UK-WP criteria a
50 Snijders et alncluded specific predilection sites of atopic dermatitis (flex-
ral involvement),6 whereas the questionnaire data were based
n the presence of an itchy rash anywhere (except diaper rash,
ash around the eyes, and scalp scaling), and thus may include
onatopic eczema.
Wright et al3 found an increased risk for asthma and
heeze in breast-fed children compared with never–breast-
ed children whose mothers had asthma themselves. Interest-
ngly, the same authors also reported higher IgE levels in
reast-fed versus never–breast-fed children of mothers with
igh IgE levels.1 In the present study, we found no effect of
reast-feeding on total IgE levels in infants of mothers with
r without high total IgE levels. We also found no effect of
reast-feeding on sensitization in the infants of mothers with
nd without sensitization, suggesting no effect modification
y maternal sensitization. We conclude that maternal atopic
tatus is not a major effect modifier of the effect of breast-
eeding on infants’ atopic manifestations. However, it should
e noted that total and specific IgE levels are only weakly
nd the development of infant eczema and
g to presence of allergy and/or asthma in the
Infant recurrent wheeze
% CI)* N n (%) OR (95% CI) ORadj (95% CI)*
167 25 (15%) 1.00 1.00
o 1.31) 353 55 (16%) 1.05 (0.63 to 1.75) 1.11 (0.62 to 2.00)
o 1.20) 198 24 (12%) 0.78 (0.43 to 1.43) 0.84 (0.36 to 1.95)
o 1.19) 194 11 (6%) 0.34 (0.16 to 0.72) 0.37 (0.14 to 1.00)
o 0.89) 247 17 (7%) 0.42 (0.22 to 0.80) 0.43 (0.16 to 1.11)
.00 .02
67 15 (22%) 1.00 1.00
o 1.57) 139 22 (16%) 0.65 (0.31 to 1.36) 0.56 (0.25 to 1.23)
o 1.71) 84 13 (16%) 0.63 (0.28 to 1.45) 0.44 (0.16 to 1.26)
o 1.38) 89 6 (7%) 0.25 (0.09 to 0.69) 0.18 (0.05 to 0.61)
o 1.29) 101 10 (10%) 0.38 (0.16 to 0.91) 0.32 (0.10 to 1.00)
.01 .02
16 5 (31%) 1.00 1.00
o 3.78) 47 13 (28%) 0.84 (0.24 to 2.89) 0.40 (0.10 to 1.51)
o 4.42) 24 7 (29%) 0.91 (0.23 to 3.58) 0.48 (0.10 to 2.32)
o 2.27) 24 3 (13%) 0.31 (0.06 to 1.57) 0.11 (0.02 to 0.70)
o 5.21) 35 6 (17%) 0.46 (0.12 to 1.80) 0.22 (0.04 to 1.09)
.01 .06
cts, the age at introduction other food products, infant sex, recruitment group, infant’s
acco smoke, maternal age at delivery, maternal education, presence of paternal allergicn a
rdin
j (95
1.00
0.61 t
0.42 t
0.40 t
0.29 t
.01
1.00
0.52 t
0.43 t
0.34 t
0.31 t
.14
1.00
0.51 t
0.44 t
0.22 t
0.53 t
.87
produ
tal tobssociated with atopic eczema and wheeze.10 Allergic sensi-
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Bization may not be a prerequisite for childhood eczema.11 An
ustralian study also showed no statistical interaction be-
ween breast-feeding and maternal asthma status for the risk
f asthma in childhood.4
Our results indicate that longer breast-feeding dura-
ion protects against recurrent wheeze irrespective of ma-
ernal allergic status. Wright et al12 followed infants during
egular visits to a health maintenance organization and
ound that in the first 4 months of life, any breast-feeding
as associated with a decreased incidence of wheezing
llnesses. Another study showed that breast-feeding for 6
onths was slightly protective against transient wheezing,
hereas it was a moderate risk factor for late-onset wheez-
ng.13 Wheezing in young children may represent a heter-
geneous group of conditions.14 It is a relatively common
ymptom in infancy, and not all wheezing will necessarily
ecome asthma in later life. We propose that our findings
n recurrent wheeze actually reflect that breast-feeding
rotects against respiratory infections in early childhood.
ndeed, infections have been found to be related to wheez-
ng symptoms. For instance, Lemanske et al15 reported
hat in the first year of life, a virus could be found during
wheezing episode in 78% of severe wheezers and in 63%
f mild wheezers. Earlier, Chantry et al16 found that full
reast-feeding for 6 months provided more protection
gainst respiratory tract infection than full breast-feeding
or 4 but 6 months.
There are several reasons why effect modification by
aternal allergic status is important. First, it has been stated
hat a lack of stratification by maternal asthma and allergic
redisposition in the child may have obscured how the rela-
ionship between breast-feeding and atopic manifestations
hanges with the child’s age and atopic status.17 Second, the
ilk composition may differ in allergic and nonallergic moth-
rs in such a way so as to affect atopic manifestations in the
hild.3 Not only cytokines, but also long-chain polyunsatu-
ated fatty acid levels, may differ between atopic and nona-
opic mothers.18-20
Taken together, we demonstrated that only the rela-
ionship between breast-feeding and infant eczema in the first
years of life may be modified by maternal allergic status,
ecause a protective effect of breast-feeding duration on ec-
ema seemed to be present mainly for mothers without allergy
r asthma, after adjustment for confounders including age at
ntroduction of cow’s milk or other food products. The pro-
ective effect of breast-feeding against recurrent wheeze was 1
reast-Feeding Duration and Infant Atopic Manifestations, by Maternal Abserved irrespective of maternal allergic status, and we spec-
late that these results may reflect protection against respira-
ory illness.
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3able 1. Baseline characteristics in both recruitment
Con
(n
reast-feeding, n (%)
Never 407
0 to 3 months 913
4 to 6 months 357
7 to 9 months 285
9 months 267
ge at introduction of cow’s milk products, n (%)
0 to 3 months 1016
4 to 6 months 615
7 to 9 months 459
9 months 46
Unknown 57
se of hypoallergenic formulas, n (%)
Yes 163
ge at introduction of other foods products, n (%)
3 months 178
4 to 6 months 1846
7 months 48
Unknown 157
ex of infants, no of boys (%) 1133
aternal age in years, mean (SD) 31
aternal smoking during pregnancy, n (%) 189
nvironmental tobacco smoking, n (%) 110
aternal education, n (%)
Low 256
Middle 857
High 993
Unknown 123
arental allergic disease, n (%)
Both parents nonallergic 878
Only father allergic 460
Only mother allergic 496
Both parents allergic 288
Unknown 107
umber of siblings, n (%)
0 siblings 1804
1 sibling 286
2 or more siblings 42
Unknown 97
resence of older allergic siblings, n (%)
No siblings 1804
Older nonallergic sibling(s) 249
Older allergic sibling(s) 85
Unknown 91
nfant’s use of antibiotics, n (%)
Yes 430
Unknown 187
D, standard deviation.
Numbers may not add up to the total because of missing values.groups
ventional
 2229)
Alternative
(n  476)
Total
(n  2705)
(18%) 11 (2%) 418 (16%)
(41%) 64 (13%) 977 (36%)
(16%) 71 (15%) 428 (16%)
(13%) 115 (24%) 400 (15%)
(12%) 215 (45%) 482 (18%)
(46%) 51 (11%) 1067 (39%)
(29%) 137 (29%) 788 (29%)
(21%) 242 (51%) 701 (26%)
(2%) 28 (6%) 74 (3%)
(3%) 18 (4%) 75 (3%)
(7%) 22 (5%) 185 (7%)
(8%) 20 (4%) 198 (7%)
(83%) 411 (86%) 2257 (83%)
(2%) 27 (6%) 75 (3%)
(7%) 18 (4%) 175 (7%)
(51%) 240 (50%) 1373 (51%)
(4) 34 (4) 32 (4)
(9%) 3 (1%) 192 (7%)
(5%) 2 (1%) 112 (4%)
(12%) 18 (4%) 274 (10%)
(39%) 83 (17%) 940 (35%)
(45%) 362 (76%) 1355 (50%)
(6%) 13 (3%) 136 (5%)
(40%) 186 (40%) 1064 (39%)
(21%) 110 (23%) 570 (21%)
(22%) 105 (22%) 601 (22%)
(13%) 69 (15%) 357 (13%)
(5%) 6 (1%) 113 (4%)
(81%) 369 (78%) 2173 (80%)
(13%) 81 (17%) 367 (14%)
(2%) 22 (5%) 64 (2%)
(4%) 4 (1%) 101 (4%)
(81%) 369 (78%) 2173 (80%)
(13%) 71 (15%) 320 (12%)
(2%) 35 (7%) 120 (4%)
(4%) 1 (1%) 92 (3%)
(19%) 56 (12%) 486 (18%)
(8%) 15 (3%) 202 (8%)51.e1 Snijders et al The Journal of Pediatrics • October 2007
Table III. Associations between breast-feeding duration and infant increased total IgE and sensitization at age 2 years, according to presence
of increased total IgE/sensitization in the mother
Maternal status
Infant increased total IgE Infant sensitization
N n (%) OR (95% CI) ORadj (95% CI) N n (%) OR (95% CI) ORadj (95% CI)
Maternal total IgE 100
IU/mL
No maternal
sensitization
BF
Never 68 24 (35%) 1.00 1.00 Never 52 11 (21%) 1.00 1.00
0 to 3 months 150 70 (47%) 1.60 (0.89 to 2.90) 1.81 (0.95 to 3.46) 0 to 3 months 97 23 (24%) 1.35 (0.56 to 3.25) 1.35 (0.53 to 3.43)
4 to 6 months 124 75 (61%) 2.81 (1.52 to 5.19) 2.34 (0.93 to 5.93) 4 to 6 months 81 26 (32%) 1.52 (0.60 to 3.82) 2.03 (0.60 to 6.88)
7 to 9 months 117 63 (54%) 2.14 (1.16 to 3.96) 1.71 (0.65 to 4.45) 7 to 9 months 74 17 (23%) 1.80 (0.74 to 4.39) 2.72 (0.80 to 9.25)
9 months 142 85 (60%) 2.73 (1.50 to 4.98) 1.80 (0.67 to 4.82) 9 months 91 22 (24%) 0.98 (0.39 to 2.48) 1.59 (0.45 to 5.66)
Ptrend .00 .65 Ptrend 1.00 .80
Maternal total IgE 100
IU/mL
Maternal
sensitization
BF
Never 21 10 (48%) 1.00 1.00 Never 35 9 (26%) 1.00 1.00
0 to 3 months 37 20 (54%) 1.29 (0.44 to 3.78) 1.34 (0.43 to 4.19) 0 to 3 months 88 28 (32%) 1.16 (0.51 to 2.61) 1.35 (0.57 to 3.18)
4 to 6 months 18 11 (61%) 1.75 (0.49 to 6.30) 1.49 (0.34 to 6.64) 4 to 6 months 61 21 (34%) 1.76 (0.78 to 3.97) 2.86 (0.91 to 8.92)
7 to 9 months 29 15 (52%) 1.19 (0.39 to 3.68) 0.88 (0.22 to 3.45) 7 to 9 months 73 28 (38%) 1.11 (0.47 to 2.62) 1.91 (0.58 to 6.25)
9 months 23 19 (83%) 5.21 (1.32 to 20.67) 4.66 (0.94 to 23.18) 9 months 71 18 (25%) 1.19 (0.52 to 2.70) 2.39 (0.72 to 7.96)
Ptrend .05 .31 Ptrend .85 .50
May not add up to total numbers because of missing values.
BF, breastfeeding.
*Based on logistic regression analysis adjusted for age at introduction of cow’s milk products, age at introduction other food products, sex of infant, recruitment group, infant’s use of antibiotics, maternal smoking during pregnancy, infant’s
exposure to environmental tobacco smoke, maternal age at delivery, maternal education, presence of paternal allergic disease, number of siblings, and presence of older allergic siblings.
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